The funding round was supported by existing backers Ada Ventures and Maersk alongside lenders HSBC and Blackrock.
"Despite a challenging fundraising environment, the latest investment round is a testament to the confidence our investors have in our long-term vision and strategy. Our team has worked incredibly hard over the last 12 months to maintain our growth trajectory despite a poor macro outlook for eCommerce, introducing new services, like introducing automation for Enterprise clients, to enhance our customers’ experience and sustain our mission to revolutionise, simplify and transform eCommerce fulfilment."
The financing was led by SoftBank Vision Fund 2 with participation from Novo Holdings and Blackrock to expand the proprietary drug pipeline.
"We believe Exscientia’s innovative use of AI to discover and design better quality drugs with greater efficiency has the potential to create important medicines faster than ever before. With the convergence of technology and biology, drug discovery is rapidly evolving in ways that will reshape the industry. The Exscientia team have been leaders in AI-based drug discovery since the field’s inception and we believe they will continue shaping its future."
— Eric Chen, Managing Partner of SoftBank Investment Advisers
The financing round was led by General Catalyst alongside several other prominent institutional investors.
"Over the past few months we have seen an acceleration in the shift from offline to online car buying as UK consumers have continued to embrace our unique and market-leading proposition. This latest funding demonstrates the conviction of some of the world’s best investors in both our business model and team as well as the UK market and gives Cazoo the firepower to deliver on our plans to provide the best possible car buying experience for UK consumers."
